Efferent Labs Announces Patents in South Korea, Europe & Mexico, Expanding Global IP Protection for CytoComm® Platform
Efferent Labs expands global IP with new patents in South Korea, Europe & Mexico, strengthening protection for its CytoComm® preclinical biosensor platform. MOUNT PLEASANT, SC, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Efferent Labs, …